46 results
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
8 May 24
Mirum Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
4:04pm
was also an important step in bringing our high impact medicines to the rare disease patient community. We look forward to continuing this momentum
S-3ASR
6t3nhicyodojcvmn
13 Oct 23
Automatic shelf registration
4:47pm
8-K
EX-99.1
uq54zmja08tmijg
13 Oct 23
Other Events
4:16pm
8-K
EX-99.1
oervf58
5 Sep 23
Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics
8:36am
8-K
EX-99.1
6hriu0x2a w6na8l58q
3 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
wpkezal99 ze2
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-99.1
djad7qughc3
24 Oct 22
Regulation FD Disclosure
8:46am
8-K
EX-99.1
b1h52 u2ip6jx
9 Mar 22
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update
4:05pm